We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Topical cosmetic ingredient — not a dietary supplement
PDRN / Polynucleotides (topical) is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most PDRN / Polynucleotides (topical) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2012–2025 with a typical study size of 27 participants.
Based on 6 studies · 3 RCTs · 263 total participants
Confidence
ModerateBy outcome
PDRN / Polynucleotides (topical) has an evidence score of 4/10 — emerging evidence based on 6 indexed studies. DNA-fragment actives (polydeoxyribonucleotide/polynucleotides, marketed as 'salmon DNA') used for skin regeneration and hydration. The crucial honest distinction: the real evidence is for INJECTABLE PDRN/polynucleotides — including a large RCT for wound healing and small cosmetic 'skin booster' trials — NOT for topical creams/serums. Large DNA fragments penetrate intact skin poorly, and there are essentially no controlled trials of topical 'salmon DNA' skincare. The mechanism (adenosine A2A receptor + nucleotide salvage → fibroblast collagen, angiogenesis, anti-inflammatory) is real, but a topical product should not be assumed to do what the injectable does. Promising as an injectable; unproven as a cream. Representative study: PMID 39645667.
Practical, evidence-based guides that cover PDRN / Polynucleotides (topical).
Explore: Best supplements for Skin, Hair & Beauty
Last reviewed June 2026 · evidence from 6 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
PDRN / Polynucleotides ('salmon DNA', topical)
DNA-fragment actives (polydeoxyribonucleotide/polynucleotides, marketed as 'salmon DNA') used for skin regeneration and hydration. The crucial honest distinction: the real evidence is for INJECTABLE PDRN/polynucleotides — including a large RCT for wound healing and small cosmetic 'skin booster' trials — NOT for topical creams/serums. Large DNA fragments penetrate intact skin poorly, and there are essentially no controlled trials of topical 'salmon DNA' skincare. The mechanism (adenosine A2A receptor + nucleotide salvage → fibroblast collagen, angiogenesis, anti-inflammatory) is real, but a topical product should not be assumed to do what the injectable does. Promising as an injectable; unproven as a cream.
PDRN/polynucleotides have a clear mechanism and genuinely respectable INJECTABLE evidence (a large wound-healing RCT; small cosmetic skin-booster trials) — but that evidence is for injection, not topical; large DNA fragments penetrate intact skin poorly, and there are essentially no controlled trials of topical 'salmon DNA' skincare, so the cosmetic-cream use case is largely unproven.
PDRN (polydeoxyribonucleotide) and polynucleotides (PN) are DNA-derived actives — typically extracted from salmon/trout sperm, hence 'salmon DNA' — used in regenerative skin treatments.
This entry covers the TOPICAL framing (creams/serums marketed as polynucleotide/salmon-DNA skincare), but the central honesty point is a route distinction: essentially all the real efficacy evidence is for INJECTABLE PDRN/PN, not topical application.
Mechanistically PDRN activates the adenosine A2A receptor and feeds the nucleotide salvage pathway, driving angiogenesis, anti-inflammatory activity, and fibroblast collagen production.
The strongest data are injectable and off-cosmetic-target: a large multicenter double-blind placebo-controlled RCT (Squadrito et al., 2014; n=216) showed injected PDRN roughly doubled healing of diabetic foot ulcers, and a smaller RCT (Kim et al., 2017; n=20) showed improved tissue oxygenation (though vessel density was non-significant).
For cosmetic rejuvenation, the evidence is injectable 'skin booster' work: a split-face RCT (Lee et al., 2022; n=27) found injectable polynucleotide comparable to — not better than — hyaluronic-acid filler, and a 2025 systematic review (Lampridou et al.) of nine low-to-moderate-quality studies (219 patients, all injectable PN) found promising but unvalidated signals, with industry ties.
Mechanism is corroborated by animal (Polito et al., 2012) and in-vitro work (Kim et al., 2023).
The decisive caveat for THIS entry: topical creams/serums face poor penetration of large DNA fragments through intact skin, and there are essentially no controlled human trials of topical PDRN/PN skincare — so the injectable evidence should not be transferred to a cream.
So the honest summary: PDRN/polynucleotides are a mechanistically sound, evidence-backed injectable for wound healing (and a promising injectable skin booster), but topical 'salmon DNA' skincare is largely unproven. None of this is a health claim.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
PDRN activates the adenosine A2A receptor and supplies nucleotides via the salvage pathway, stimulating angiogenesis, dampening inflammation, and promoting fibroblast proliferation and collagen production. This is the well-supported regenerative mechanism — demonstrated in vitro, in animals, and in injectable clinical use.
The efficacy evidence is for PDRN/polynucleotides delivered by injection. Large DNA fragments penetrate intact skin poorly, so a topical cream cannot be assumed to deliver the same effect — the central limitation of topical 'salmon DNA' skincare.
Topical 'salmon DNA' creams/serums are applied to skin per the product, but topical efficacy is essentially unproven (poor penetration of large DNA fragments). The evidence-backed forms are injectable (medical/aesthetic procedures performed by clinicians), which are outside the scope of a topical cosmetic entry. There is no oral or systemic consumer dose here. This library does not provide an ingestion protocol.
| Form | Type |
|---|---|
| 🧴Injectable PDRN/PN under a clinician has the evidence; topical 'salmon DNA' skincare is largely unproven | Recommended |
| 🧴Better-evidenced topical actives (retinoids, vitamin C, hyaluronic acid) for at-home use | Alternative |
There is no oral or consumer-injectable form covered here. Injectable PDRN/PN is a clinician-administered procedure.
Minimum: 8 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Topical products are applied per the label, but topical efficacy is unproven. As a topical there is no ingestion or meal-timing consideration.
PDRN/polynucleotides are evidence-backed as injectables (wound healing; skin boosters). Topical 'salmon DNA' creams/serums are a different, largely unproven use because large DNA fragments penetrate intact skin poorly. This is a cosmetic, not a medical, claim.
Injectable polynucleotide 'skin boosters' improved skin quality in small trials — but only comparably to hyaluronic-acid filler, and this is injection, not a topical product.
Injected PDRN roughly doubled diabetic-foot-ulcer healing in a large RCT — strong evidence, but for a medical wound-healing indication via injection, not cosmetic topical use.
There are essentially no controlled human trials of topical PDRN/PN skincare; do not assume a cream delivers the injectable's benefits. Treat marketing claims skeptically.
No safety data for topical or injectable PDRN/PN in pregnancy; avoid and consult a clinician.
Avoid — PDRN is salmon/trout-derived; allergic reaction is possible.
Know that the evidence is for injectable use by a clinician; topical creams are largely unproven. Choose better-evidenced at-home actives for daily skincare.
Topical polynucleotide products generally layer with other actives; combining many can irritate sensitive skin. Not a systemic interaction — it is not ingested. (Injectable use has its own procedural considerations.)
Tip: Discontinue if irritation occurs.
Tip: Avoid if allergic to fish/salmon; patch-test.
Tip: Bruising, swelling, or nodules relate to injectable use by a clinician — not the topical product covered here.
The commonly studied dose of PDRN / Polynucleotides (topical) is Topical 'salmon DNA' creams/serums are applied to skin per the product, but topical efficacy is essentially unproven (poor penetration of large DNA fragments). The evidence-backed forms are injectable (medical/aesthetic procedures performed by clinicians), which are outside the scope of a topical cosmetic entry. There is no oral or systemic consumer dose here. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for PDRN / Polynucleotides (topical) — consistent daily use matters more than the time of day. Topical polynucleotide products are leave-on cosmetics with no meal-timing relationship; penetration (not timing) is the limiting factor.
PDRN / Polynucleotides (topical) is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are mild local irritation (topical), fish-allergy reaction, injection-related effects (injectable forms only). Use caution if any of these apply to you: This entry covers topical use only — injectable PDRN/PN is a clinician-administered procedure with its own risks; Known allergy to fish/salmon-derived products (source of PDRN); Application to broken or irritated skin until healed.
Daily broad-spectrum sunscreen — the single most evidence-based anti-aging skincare step there is, and the one most 'anti-aging' actives are really just trying to compensate for. The honest framing: this is the only topical on this list backed by a proper randomized controlled trial for skin aging itself. In the landmark Hughes 2013 trial (n=903), people randomized to daily sunscreen showed 24% less photoaging over 4.5 years — and no detectable increase in skin aging at all — while the mechanism (UV → matrix-metalloproteinase activation → collagen breakdown) is textbook. The same trial cohort also had less skin cancer. The honest caveats: the benefit is overwhelmingly prevention, not reversal of existing damage; real-world results depend entirely on applying enough and reapplying; and chemical (organic) UV filters are systemically absorbed above an FDA testing threshold (clinical significance unknown — mineral zinc-oxide/titanium-dioxide filters sidestep this). If you do one thing for your skin, it's this.